RECENT POSTS

18

Jul, 2014

Clinical Trials – Multi Site

By: | Tags: , , | Comments: 0

BioMark is proud to partner and cooperate with National Cancer Institute in Bangladesh and BioMark China in a phase III multi site trial. The trail will involve over 400 subjects and will focus on 4 cancer indications. All the procedures will follow North American regulatory guidelines that were prepared by Saint Boniface Research centre’s regulatory group.

READ MORE

18

Jul, 2014

New Scientific Advisory Board

By: | Tags: , , | Comments: 0

BioMark would like to introduce and welcome 2 new members to its scientific advisory board. The new members are: Dr. Samudra Dissanayake, Director Strategic Initiatives and Business Development Health-Tech-Connex Dr. Dissanayake has been an important contributor in the development of BioMark’s technology platform for cancer screening, response to treatment and cancer treatment. Dr. Dissanayake role would be to advise the management team on how to develop critical relationships with agencies…

READ MORE